Vanguard Group Inc Anixa Biosciences Inc Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Anixa Biosciences Inc stock. As of the latest transaction made, Vanguard Group Inc holds 1,392,906 shares of ANIX stock, worth $3.94 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,392,906
Previous 1,392,906
-0.0%
Holding current value
$3.94 Million
Previous $3.45 Million
15.32%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ANIX
# of Institutions
63Shares Held
5.48MCall Options Held
24.5KPut Options Held
23.4K-
Laird Norton Trust Company, LLC622KShares$1.76 Million0.29% of portfolio
-
D.A. Davidson & Co.614KShares$1.74 Million0.01% of portfolio
-
Ubs Group Ag524KShares$1.48 Million0.0% of portfolio
-
Mission Wealth Management, LP470KShares$1.33 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA340KShares$962,9490.0% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $86.8M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...